What does clonus of a unilateral upper limb and the pectoral muscles indicate, and how should it be evaluated and managed?

Unilateral Upper Limb and Pectoral Clonus: Evaluation and Management

Unilateral upper limb clonus involving the pectoralis muscles indicates an upper motor neuron lesion and should be managed with intramuscular botulinum toxin-A injections as first-line treatment when the clonus significantly impacts function, comfort, or hygiene.

Understanding the Clinical Significance

Clonus represents involuntary, rhythmic muscle contractions at 5-8 Hz caused by permanent descending motor neuron lesions 1. When occurring unilaterally in the upper extremity with pectoral involvement, this pattern strongly suggests:

• Stroke (capsular or hemispheric)
• Cervical spinal cord injury or myelopathy
• Central motor pathway lesions affecting corticospinal tracts

The unilateral distribution is critical—it localizes the lesion to contralateral brain structures or ipsilateral cervical cord 2.

Mechanism

The pathophysiology involves two components 3:

1. Hyperactive stretch reflexes from increased motor unit pool gain and decreased threshold
2. Altered tissue viscoelasticity with decreased optimal muscle length and increased passive stiffness

Importantly, clonus is NOT solely due to recurrent muscle stretch—central oscillator mechanisms contribute significantly 4. The first clonic beat is always longer, with subsequent beats stabilizing by the 4th-5th oscillation 1.

Immediate Evaluation Algorithm

Step 1: Confirm upper motor neuron syndrome

• Exaggerated deep tendon reflexes on affected side
• Spasticity with velocity-dependent resistance
• Motor weakness (often present)
• Babinski sign

Step 2: Neuroimaging within 24-48 hours

• MRI brain and cervical spine (preferred): Identifies stroke, myelopathy, cord compression, demyelination
• Look specifically for: signal changes in corticospinal tracts, cord compression at C3-C7, capsular infarcts
• CT if MRI contraindicated, though less sensitive for cord pathology

Step 3: Assess functional impact

• Activities of daily living interference (dressing, feeding, hygiene)
• Pain or discomfort from sustained contractions
• Cosmetic concerns affecting social participation
• Sleep disruption

Treatment Strategy

First-Line: Botulinum Toxin-A Injections

Intramuscular botulinum toxin-A is the treatment of choice for functionally significant upper extremity clonus 5. This approach directly addresses the hyperactive motor units while avoiding systemic side effects.

Injection protocol:

• Target muscles: Pectoralis major, biceps brachii, wrist/finger flexors (based on clonus distribution)
• Dose: 100-300 units total (divided among affected muscles)
• Expect improvement within 1-2 weeks, lasting 3-4 months
• Repeat injections as needed

Second-Line: Oral Medications

If botulinum toxin unavailable or patient preference:

• Baclofen: Start 5 mg TID, titrate to 20 mg TID (maximum 80 mg/day)

  • GABA-B agonist reducing motor neuron excitability
  • Monitor for sedation, weakness

• Tizanidine: Alternative alpha-2 agonist if baclofen not tolerated

Adjunctive Physical Therapy Strategies

Based on functional neurological disorder principles that apply to spasticity management 6:

• Avoid cocontraction: Discourage tensing muscles to suppress clonus—this worsens long-term outcomes
• Relaxation techniques: Diaphragmatic breathing, progressive muscle relaxation
• Optimal positioning: Maintain neutral joint alignment; avoid end-range positions
• Graded functional activities: Use affected limb in bilateral tasks with even weight distribution
• Cold application: Can temporarily reduce clonus severity 1

Interventions to AVOID

• Splinting/serial casting: Increases attention to affected area, promotes compensatory patterns, risks complex regional pain syndrome 6
• Prolonged immobilization: Leads to muscle deconditioning and learned non-use
• Phenol injections: Reserved only for severe, refractory cases due to permanent nerve damage risk

Special Considerations

Cervical myelopathy context 7: If clonus emerged after cervical spine trauma or progressive myelopathy, surgical decompression timing matters. However, clonus itself is NOT an indication for urgent surgery—focus on preventing further cord injury if compression present.

Stroke context 2: Action-induced clonus may mimic tremor. Key distinguishing features:

• Same frequency during passive stretch and active movement
• Associated with spasticity and hyperreflexia
• Responds to stretch reflex modulation (botulinum toxin)

Monitoring response:

• Video recording (with consent) helps document changes in amplitude and frequency 6
• Reassess at 2-4 weeks post-botulinum injection
• Adjust doses/muscles targeted based on functional improvement

Prognosis

Upper extremity clonus typically persists chronically after upper motor neuron injury. However, functional impact can be substantially reduced with appropriate treatment. Some patients with incomplete injuries show gradual improvement over 6-12 months as compensatory pathways develop 7.

Red flags requiring urgent reassessment:

• Progressive weakness beyond clonus
• Ascending sensory level
• Bowel/bladder dysfunction
• Suggests evolving myelopathy requiring neurosurgical evaluation

The key is aggressive functional management with botulinum toxin while addressing the underlying neurological condition through appropriate rehabilitation and secondary stroke/injury prevention measures.